Coty’s (NYSE:COTY) Q2 CY2026 Sales Beat Estimates But Stock Drops
Coty (NYSE: COTY) reported Q2 CY2026 revenue of $1.27 billion, up 1.3% YoY, beating estimates. Non-GAAP EPS loss of $0.02 missed expectations by $0.01. Despite beating revenue estimates, shares dropped 9% to $2.77 post-results. Analysts expect a 1.3% revenue decline in the next 12 months, with organic sales down 1% YoY in Q2.
How this was made
The 30-second read
Why it matters
The earnings beat on revenue contrasts with weak organic growth and a 9% share decline, indicating mixed market reaction.
Market read
Earnings release provides fresh data for traders; the stock's sharp drop creates a potential short‑term trading opportunity.
What to watch
Potential cost‑cutting measures and upcoming product launches are not discussed.
Background
Coty is a mid‑cap beauty products company with a portfolio of cosmetics, fragrances, and skincare brands.
Ticker impact
Coty reported Q2 CY2026 revenue of $1.27 B, beating estimates by 5.7% but shares fell 9% to $2.77.
Potential further downside if guidance remains weak; upside if market re‑prices beat.
Beat on revenue but weak organic growth and negative guidance outlook drive bearish sentiment.
Market effects
Signals continued pressure on consumer staples beauty segment amid modest demand.
U.S. consumer discretionary sentiment may soften.
Limited; primarily affects U.S. beauty‑product investors.
Counterpoint
Despite the drop, the revenue beat could support a bounce if the market overreacts.
Key entities
- CompanyCoty Inc.
Beauty products manufacturer (NYSE:COTY).
